Proteinuria
72 results
1 - 72
Angiotensin‐converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease- Non‐immunosuppressive treatment for IgA nephropathy
- Pentoxifylline for diabetic kidney disease
- Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease
- Prostaglandin E1 for preventing the progression of diabetic kidney disease: Cochrane systematic review
- Immunosuppressive therapy for IgA nephropathy in children
- Interventions for chronic kidney disease in people with sickle cell disease
- Interventions for preventing and treating kidney disease in IgA vasculitis
- Immunosuppressive agents for treating IgA nephropathy
- Interventions for idiopathic steroid‐resistant nephrotic syndrome in children
- Angiogenesis-inhibitors for metastatic thyroid cancer: Cochrane systematic review
- Tripterygium wilfordii Hook F (a traditional Chinese medicine) for primary nephrotic syndrome: Cochrane systematic review
- Cordyceps sinensis (a traditional Chinese medicine) for treating chronic kidney disease: Cochrane systematic review
- Altered dietary salt intake for people with chronic kidney disease
- Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas
- Interventions for weight loss in people with chronic kidney disease who are overweight or obese
- Interventions for focal segmental glomerulosclerosis in adults
- Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non‐diabetic chronic kidney disease
- Astragalus (a traditional Chinese medicine) for treating chronic kidney disease: Cochrane systematic review
- Chinese herbal medicine Huangqi type formulations for nephrotic syndrome: Cochrane systematic review
- Antihypertensive treatment for kidney transplant recipients
- HMG CoA reductase inhibitors (statins) for kidney transplant recipients
- Plasma volume expansion for treatment of pre‐eclampsia
- Anti‐angiogenic therapies for metastatic colorectal cancer
- Chinese herbal medicines for treating pre‐eclampsia
- Protein restriction for children with chronic kidney disease
- HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
- Protein restriction for diabetic kidney disease
- Heparin and related substances for preventing diabetic kidney disease: Cochrane systematic review
- Gold as an oral corticosteroid sparing agent in stable asthma
- Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer
- Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura
- Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome
- Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
- Drugs for treatment of very high blood pressure during pregnancy
- Blood pressure targets for hypertension in people with chronic renal disease
- Uric acid lowering therapies for preventing or delaying the progression of chronic kidney disease
- Guided imagery for treating hypertension in pregnancy
- Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
- Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration: Cochrane systematic review
- Lipid-lowering agents for nephrotic syndrome: Cochrane systematic review
- Oral fumaric acid esters for psoriasis
- Antioxidants for adults with chronic kidney disease
- Interventions for preventing bone disease in kidney transplant recipients
- Antiplatelet agents for chronic kidney disease
- Interventions for renal vasculitis in adults
- Glucose targets for preventing diabetic kidney disease and its progression
- Education programmes for people with chronic kidney disease and diabetes
- Calcium supplementation commencing before or early in pregnancy, for preventing hypertensive disorders of pregnancy
- Anti‐angiogenic therapy for high‐grade glioma
- Metformin for preventing the progression of chronic kidney disease
- Synbiotics, prebiotics and probiotics for people with chronic kidney disease
- Treatment for hepatitis C virus‐associated mixed cryoglobulinaemia